These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33993220)

  • 1. PD-1 blockade prevents the progression of oral carcinogenesis.
    Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
    Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
    Wang J; Xie T; Wang B; William WN; Heymach JV; El-Naggar AK; Myers JN; Caulin C
    Cancer Prev Res (Phila); 2017 Dec; 10(12):684-693. PubMed ID: 29018057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
    Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV
    Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
    Shi Y; Xie TX; Leach DG; Wang B; Young S; Osman AA; Sikora AG; Ren X; Hartgerink JD; Myers JN; Rangel R
    Cancer Prev Res (Phila); 2021 Aug; 14(8):767-778. PubMed ID: 34021022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
    Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
    J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
    Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
    Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
    Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G
    Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma.
    Cai Y; Wang F; Liu Q; Li Z; Li D; Sun Z
    Invest New Drugs; 2019 Oct; 37(5):799-809. PubMed ID: 30368626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma.
    Chiang IT; Lee YH; Tan ZL; Hsu FT; Tu HF
    Biomed Pharmacother; 2022 Mar; 147():112661. PubMed ID: 35092865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
    Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
    J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting IL-17alpha to promote anti-PD-1 therapy effect by screening the tumor immune microenvironment in a mouse oral carcinogenesis model.
    Wang S; Yu X; Li F; Fan H; Zhao E; Hu Z
    Cancer Biomark; 2021; 31(4):339-350. PubMed ID: 33896829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
    Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM
    J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of CXCR7/ligands may be involved in oral carcinogenesis.
    Xia J; Wang J; Chen N; Dai Y; Hong Y; Chen X; Cheng B
    J Mol Histol; 2011 Apr; 42(2):175-80. PubMed ID: 21442287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.